MU
Micron Technology, Inc.
MU has the edge over TBCH overall, supported by stronger fundamentals and stronger valuation.
TBCH
Turtle Beach Corporation
TBCH's outlook is improving, though it still trails on the overall score.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
TBCH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Strong | |
| Weak |
TBCH's cash flow is currently strong, and its revenue is stable, but its profitability and balance sheet are under pressure.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
TBCH PE Valuation
TBCH has no meaningful PE right now: it lost money over the past year.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
TBCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TBCH, with profitability improving. However, they disagree widely on these estimates.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over TBCH on earnings quality, reporting a profit while its opponent remains loss making.
TBCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.16 | — |
| Q3 2026 | -$0.06 | -107% |
| Q2 2026 | -$0.22 | -123% |
| Q1 2026 | $0.02 | -97% |
| Q4 2025 | $0.77 | -1.3% |
| Q3 2025 | $0.87 | +200% |
| Q2 2025 | $0.95 | +$1.03 |
| Q1 2025 | $0.74 | +$1.40 |
| Q4 2024 | $0.78 | +$1.85 |
TBCH has swung to a loss: it lost $0.06 per share over the past year, after a profit the year before.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over TBCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over TBCH on profitability, with a higher operating margin.
TBCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84.7M | +5.3% |
| Q2 2026 | $56.4M | -0.7% |
| Q1 2026 | $42.2M | -34% |
| Q4 2025 | $118.8M | -19% |
| Q3 2025 | $80.5M | -15% |
| Q2 2025 | $56.8M | -26% |
| Q1 2025 | $63.9M | +14% |
| Q4 2024 | $146.1M | +47% |
TBCH's revenue is recovering but still below its 2024 peak: $85M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7% | +0.3 points |
| Q2 2026 | -5.4% | -4.8 points |
| Q1 2026 | -33% | -36 points |
| Q4 2025 | 18% | +1.6 points |
| Q3 2025 | 6.7% | -0.1 points |
| Q2 2025 | -0.6% | +4.8 points |
| Q1 2025 | 2.4% | +13 points |
| Q4 2024 | 16% | +7.6 points |
TBCH's operating margin was 7% last quarter, about level with the same quarter a year ago.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over TBCH on cash flow, with more consistent year-over-year improvement.
TBCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.3M | +$8.5M |
| Q2 2026 | $5.9M | +$9.4M |
| Q1 2026 | $29.1M | -28% |
| Q4 2025 | $13.1M | +2.3% |
| Q3 2025 | -$15.9M | +$8.7M |
| Q2 2025 | -$3.5M | +$10.4M |
| Q1 2025 | $40.3M | +52% |
| Q4 2024 | $12.8M | -32% |
TBCH usually generates cash, though not every quarter: the latest was −$7M, but it generated $41M over the past year.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
TBCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.1% | -985K shares |
| 1 year | -11% | -2.2M shares |
| 3 years | +4.9% | +852K shares |
| 5 years | -0.8% | -138K shares |
| Available history | +16% | +2.5M shares |
TBCH has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $25M |
| Q1 2026 | $2.2M |
| Q4 2025 | $2M |
| Q3 2025 | $10.3M |
| Q2 2025 | $5M |
| Q1 2025 | $1.8M |
| Q4 2024 | $2.4M |
TBCH spent $29M buying back its own shares over the past year, up 50% from the year before.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over TBCH on leverage, with a lower net debt burden relative to earnings.
TBCH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | 4.7x | High |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.4x | Healthy |
TBCH's net debt is about 5.2 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
TBCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.8 | Neutral |
| Stochastic | 76.0 | Neutral |
TBCH's weekly RSI is 64 (neutral) and its Stochastic is 76 (neutral).
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
TBCH PE vs Technology Sector
| Metric | TBCH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
TBCH has no meaningful PE right now: it lost money over the past year.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
TBCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 11% above |
| 20 week MA | $13.6 | 21% above |
| 50 week MA | $12.9 | 28% above |
| 100 week MA | $13.8 | 19% above |
| 200 week MA | $13.1 | 26% above |
TBCH has the edge over MU on trend strength, trading above more of its moving averages.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over TBCH on returns for 2026, with the stronger performance.
TBCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.91 | $24.7 | +178% |
| 2021 | $24.7 | $24.5 | -1.1% |
| 2022 | $24.5 | $6.99 | -71% |
| 2023 | $6.99 | $11.0 | +57% |
| 2024 | $11.0 | $16.9 | +55% |
| 2025 | $16.9 | $14.2 | -16% |
| 2026 YTD | $14.2 | $16.5 | +17% |
TBCH's yearly returns have swung widely, from +178% in 2020 to −71% in 2022. It's up 17% so far in 2026.